Additionally, in PAH patients, when corrected by body mass index (BMI), low circulating levels of leptin are associated with an increased overall mortality and the leptin/BMI ratio represented a negative predictive value for mortality at 2 years [46]. This evidence concerns the gene LEP and pulmonary arterial hypertension.